Denmark· DK-28103850805
Lamivudine/Zidovudine "GSK"
A zidovudine and lamivudine product containing lamivudin, zidovudin, registered in Denmark by Glaxo Group Limited. The same ATC class is registered in 14 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Zidovudine and lamivudine is registered in 14 of 19 countries.
Countries holding a registration under ATC J05AR01 (zidovudine and lamivudine), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Zidovudine and lamivudine · ATC J05AR01
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- LAMIVUDIN, ZIDOVUDIN
- Manufacturer
- Glaxo Group Limited
- Country
- Denmark (DK)
- ATC code
- J05AR01
- ATC class
- Zidovudine and lamivudine
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28103850805
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for zidovudine and lamivudine.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Zidovudine and lamivudine · interactions on record
1 record
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under J05AR01
Zidovudine and lamivudine, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cdff992c-6e14-4f8e-8591-1c49a31ee8b6 GET /v1/drugs/cdff992c-6e14-4f8e-8591-1c49a31ee8b6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "150+350 mg",
"auth_role": "MOD",
"dk_drugid": "28103850805",
"substance": "LAMIVUDIN, ZIDOVUDIN",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "38749"
}See everything about zidovudine and lamivudine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.